✦ LIBER ✦

Clinical Outcomes by Age in Men With Hormone Refractory Prostate Cancer: A Pooled Analysis of 8 Cancer and Leukemia Group B (CALGB) Studies

✍ Scribed by Halabi, Susan; Vogelzang, Nicholas J.; Ou, San-San; Kelly, Wm. Kevin; Small, Eric J.

Book ID: 121905762
Publisher: Lippincott Williams and Wilkins
Year: 2006
Tongue: English
Weight: 180 KB
Volume: 176
Category: Article
ISSN: 0022-5347
DOI: 10.1016/S0022-5347(06)00566-0

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Higher doses of mitoxantrone among men w

Higher doses of mitoxantrone among men with hormone-refractory prostate carcinoma : A Cancer and Leukemia Group B study

✍ Ellis G. Levine; Susan Halabi; John D. Roberts; Ellen B. Kaplan; Randall Rago; J 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 85 KB

Prognostic significance of plasma chromo

Prognostic significance of plasma chromogranin a levels in patients with hormone-refractory prostate cancer treated in Cancer and Leukemia Group B 9480 study

✍ Mary-Ellen Taplin; Daniel J. George; Susan Halabi; Ben Sanford; Philip G. Febbo; 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 122 KB

The Impact of Prior Radical Prostatectom

The Impact of Prior Radical Prostatectomy in Men With Metastatic Castration Recurrent Prostate Cancer: A Pooled Analysis of 9 Cancer and Leukemia Group B Trials

✍ Halabi, Susan; Vogelzang, Nicholas J.; Ou, San-San; Small, Eric J. 📂 Article 📅 2007 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 107 KB

A Phase II Study of Estramustine, Doceta

A Phase II Study of Estramustine, Docetaxel, and Exisulind in Patients with Hormone- Refractory Prostate Cancer: Results of Cancer and Leukemia Group B Trial 90004

✍ Nancy A. Dawson; Susan Halabi; San-San Ou; David D. Biggs; Anne Kessinger; Nicho 📂 Article 📅 2008 🏛 CIG Media Group, LP. 🌐 English ⚖ 130 KB

The dynamics of prostate specific antige

The dynamics of prostate specific antigen in hormone refractory prostate carcinoma : An analysis of Cancer and Leukemia Group B Study 9181 of megestrol acetate

✍ Robin T. Vollmer; Nancy A. Dawson; Nicholas J. Vogelzang 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 113 KB 👁 2 views

## BACKGROUND. Although many physicians measure serum prostate specific antigen (PSA) during the follow-up of patients with hormone refractory prostate carcinoma (HRPC), little has been done to formalize the determination of how these serial values of PSA impact on prognosis. To understand HRPC fu

A phase 2 study of estramustine, docetax

A phase 2 study of estramustine, docetaxel, and bevacizumab in men with castrate-resistant prostate cancer : Results from Cancer and Leukemia Group B Study 90006

✍ Joel Picus; Susan Halabi; W. Kevin Kelly; Nicholas J. Vogelzang; Young E. Whang; 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 184 KB 👁 2 views